CD8A and hepatocellular carcinoma: However, it is thought that lasting CD8 T cell dysfunction after HCV cure will result in a failure to generate effective HCV vaccine responses in vulnerable populations (99) and potentially contribute to the development of HCC and poor responses to immunotherapy.